# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
3003, Journal, 3, 15, "J Ophthalmol", "", "<http://ctro/data#Publication_8462> <http://ctro/data#hasJournal> \"J Ophthalmol\"."
3004, PublicationYear, 18, 22, "2000", "", "<http://ctro/data#Publication_8462> <http://ctro/data#hasPublicationYear> \"2000\"."
3013, Title, 51, 177, "A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension : a 3 month , randomised study .", "", "<http://ctro/data#Publication_8462> <http://ctro/data#hasTitle> \"A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension : a 3 month , randomised study .\"."
3005, Latanoprost, 67, 78, "latanoprost", "", 
3006, Dorzolamide, 83, 94, "dorzolamide", "", 
3007, Glaucoma, 112, 120, "glaucoma", "", "<http://ctro/data#Glaucoma_8478> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glaucoma>. <http://ctro/data#ClinicalTrial_8469> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Glaucoma_8478>."
3008, OcularHypertension, 125, 144, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
3009, Duration, 149, 156, "3 month", "", "<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasCTduration> \"3 month\"."
3010, Randomized, 159, 169, "randomised", "", "<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
3011, Ireland, 178, 185, "Ireland", "", 
3012, Author, 212, 224, "O ' Donoghue", "", "<http://ctro/data#Publication_8462> <http://ctro/data#hasAuthor> \"O ' Donoghue\"."
3065, Ireland, 332, 339, "Ireland", "", 
3023, ObjectiveDescription, 366, 540, "To compare the effects on intraocular pressure ( IOP ) and side effects of monotherapy with either latanoprost or dorzolamide in patients with glaucoma or ocular hypertension", "", "<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasObjectiveDescription> \"To compare the effects on intraocular pressure ( IOP ) and side effects of monotherapy with either latanoprost or dorzolamide in patients with glaucoma or ocular hypertension\"."
3015, IOP, 392, 412, "intraocular pressure", "", 
3014, IOP, 415, 418, "IOP", "", 
3016, Latanoprost, 465, 476, "latanoprost", "", 
3017, Dorzolamide, 480, 491, "dorzolamide", "", 
3018, Glaucoma, 509, 517, "glaucoma", "", 
3019, OcularHypertension, 521, 540, "ocular hypertension", "", 
3020, NumberPatientsCT, 553, 556, "224", "", "<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasNumberPatientsCT> \"224\"."
3641, OpenAngleGlaucoma, 571, 590, "open angle glaucoma", "", 
3026, OcularHypertension, 594, 613, "ocular hypertension", "", 
3025, Duration, 634, 641, "3 month", "", 
3024, OpenLabel, 642, 655, "open labelled", "", "<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
3028, Precondition, 664, 709, "Previous glaucoma medications were washed out", "", "<http://ctro/data#Population_8484> <http://ctro/data#hasPrecondition> \"Previous glaucoma medications were washed out\"."
3029, Randomized, 732, 742, "randomised", "", 
3030, Latanoprost, 761, 772, "latanoprost", "", 
3031, DoseValue, 773, 780, "0 . 005", "", 
3032, Percentage, 781, 782, "%", "", 
3033, Frequency, 783, 793, "once daily", "", 
3034, Dorzolamide, 797, 808, "dorzolamide", "", 
3035, DoseValue, 809, 810, "2", "", 
3036, Percentage, 811, 812, "%", "", 
3037, Frequency, 813, 830, "three times daily", "", 
3022, NumberPatientsCT, 846, 849, "224", "", 
3269, NumberPatientsCT, 859, 862, "213", "final", 
3038, Duration, 913, 921, "3 months", "", 
3039, Latanoprost, 924, 935, "latanoprost", "", 
3040, Mean, 944, 948, "mean", "", 
3041, Diurnal_IOP, 958, 969, "diurnal IOP", "", 
3042, BaseLineValue, 975, 981, "27 . 2", "", 
3043, SdDevBL, 984, 992, "SD 3 . 0", "", 
3044, mmHg, 995, 1000, "mm Hg", "", 
3045, Reduction, 1004, 1009, "8 . 5", "", 
3046, SdDevChangeValue, 1012, 1017, "3 . 3", "", 
3047, mmHg, 1020, 1025, "mm Hg", "", 
3048, Dorzolamide, 1058, 1069, "dorzolamide", "", 
3049, BaseLineValue, 1075, 1081, "27 . 2", "", 
3050, SdDevBL, 1084, 1089, "3 . 4", "", 
3051, Reduction, 1096, 1101, "5 . 6", "", 
3052, SdDevChangeValue, 1104, 1109, "2 . 6", "", 
3053, mmHg, 1112, 1117, "mm Hg", "", 
3056, DiffBetweenGroups, 1138, 1143, "2 . 9", "", 
3058, mmHg, 1144, 1149, "mm Hg", "", 
3059, ConfIntervalDiff, 1152, 1175, "95 % CI : 2 . 3 - 3 . 6", "", 
3060, PvalueDiff, 1203, 1214, "p < 0 . 001", "", 
3062, Latanoprost, 1228, 1239, "Latanoprost", "", 
3063, IOP, 1248, 1251, "IOP", "", 
3067, Peak_IOP, 1252, 1274, "at peak by 8 . 6 mm Hg", "", 
3068, Reduction, 1263, 1268, "8 . 6", "", 
3069, mmHg, 1269, 1274, "mm Hg", "", 
3070, RelativeReduction, 1277, 1279, "32", "", 
3071, Reduction, 1298, 1303, "6 . 2", "", 
3072, mmHg, 1304, 1311, "mm Hg (", "", 
3073, RelativeReduction, 1312, 1314, "23", "", 
3074, Dorzolamide, 1323, 1334, "dorzolamide", "", 
3075, DiffBetweenGroups, 1359, 1364, "2 . 4", "", 
3076, mmHg, 1365, 1370, "mm Hg", "", 
3077, PvalueDiff, 1389, 1400, "p < 0 . 001", "", 
3078, TimePoint, 1443, 1449, "trough", "", 
3079, Reduction, 1455, 1460, "8 . 1", "", 
3080, mmHg, 1461, 1466, "mm Hg", "", 
3081, RelativeReduction, 1469, 1471, "31", "", 
3082, Latanoprost, 1480, 1491, "latanoprost", "", 
3083, Reduction, 1496, 1501, "4 . 7", "", 
3084, mmHg, 1502, 1507, "mm Hg", "", 
3085, RelativeReduction, 1510, 1512, "17", "", 
3086, Dorzolamide, 1521, 1532, "dorzolamide", "", 
3087, DiffBetweenGroups, 1563, 1568, "3 . 4", "", 
3088, mmHg, 1569, 1574, "mm Hg", "", 
3089, PvalueDiff, 1577, 1588, "p < 0 . 001", "", 
3090, ObservedResult, 1602, 1657, "Both drugs were well tolerated systemically and locally", "", 
3094, Latanoprost, 1673, 1684, "Latanoprost", "", 
3096, ConclusionComment, 1673, 1821, "Latanoprost was superior to dorzolamide in reducing the IOP , judged both from the effect on IOP at peak and trough and by the effect on diurnal IOP", "", "<http://ctro/data#ClinicalTrial_8469> <http://ctro/data#hasConclusionComment> \"Latanoprost was superior to dorzolamide in reducing the IOP , judged both from the effect on IOP at peak and trough and by the effect on diurnal IOP\"."
3095, Dorzolamide, 1701, 1712, "dorzolamide", "", 
3092, IOP, 1729, 1732, "IOP", "", 
3093, Peak_IOP, 1766, 1769, "IOP", "", 
3091, Diurnal_IOP, 1810, 1821, "diurnal IOP", "", 
3097, PMID, 1887, 1895, "10837379", "", "<http://ctro/data#Publication_8462> <http://ctro/data#hasPMID> \"10837379\"."
